​
​

Abeona Therapeutics Ownership | Who Owns Abeona Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

Abeona Therapeutics Ownership Summary

Abeona Therapeutics is owned by 2.39% institutional investors, and 97.61% retail investors. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.85% of its assets in Abeona Therapeutics shares.

ABEO Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAbeona Therapeutics2.39%-97.61%
SectorHealthcare Stocks 47.31%8.01%44.69%
IndustryBiotech Stocks 45.43%7.81%46.75%

Institutional Shareholders

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20222-94.44%153,702-99.26%21.16%--100.00%2-60.00%
Jun 30, 202236-26.53%20,889,690-35.97%142.84%11-31.25%5-66.67%
Mar 31, 2022494.26%32,623,572-20.40%221.30%16-27.27%1525.00%
Dec 31, 202147-16.07%40,985,64961.98%416.24%2222.22%12-36.84%
Sep 30, 202156-18.84%25,302,696-9.04%253.11%18-37.93%19-20.83%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.23M2.85%-
Vanguard Institutional Extnd Mkt Idx Tr703.06K1.62%-
Simplify Propel Opportunities ETF408.58K0.94%-
abrdn Life Sciences Investors327.00K0.75%-
Fidelity Extended Market Index240.13K0.55%-3.55K
BlackRock Extended Equity Market K96.05K0.22%-41.00
iShares Micro-Cap ETF89.30K0.21%-
Fidelity Total Market Index75.75K0.17%14.06K
Fidelity Series Total Market Index55.47K0.13%-1.69K
NT Ext Equity Mkt Idx Fd - NL49.25K0.11%-

Recent Insider Transactions

DateNameRoleActivityValue
Jun 18, 2024Alvino Mark-Sell$116.76K
Jun 18, 2024Silverstein Christine Berni-Sell$116.45K
May 16, 2024Alland Leila-Buy$51.80K
May 07, 2024Adage Capital Management, L.P.-Buy-
Apr 25, 2024Seshadri Vishwas Chief Executive OfficerBuy$32.00K

Insider Transactions Trends

DateBuySell
2024 Q4--
2024 Q3--
2024 Q262
2024 Q111
2023 Q4--

ABEO Ownership FAQ

Who Owns Abeona Therapeutics?

Abeona Therapeutics shareholders are primarily institutional investors at 2.39%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Abeona Therapeutics's industry, Biotech Stocks , is 45.43%, which Abeona Therapeutics falls below.

Does Blackrock own Abeona Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Abeona Therapeutics.

Who is the top mutual fund holder of Abeona Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Abeona Therapeutics shares, with 2.85% of its total shares outstanding invested in 1.23M Abeona Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools